| Typicality: | 0.508 |
| Saliency: | 0.320 |
| in australia | 8 | location |
| by the therapeutic goods administration | 5 | other |
| for soon | 5 | temporal |
| medicine → be approved for → sale | 11 |
| medicine → be approved for → marketing | 8 |
| negative | neutral | positive |
| 0.069 | 0.667 | 0.264 |
| Raw frequency | 19 |
| Normalized frequency | 0.320 |
| Modifier score | 0.875 |
| Perplexity | 42.542 |